Public Calendar: June 25 - July 1, 2017
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs
No Significant Event
Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name : Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine
No Significant Event
Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name : Peter Lurie, M.D., M.P.H., Associate Commissioner for Policy and Planning
No Significant Event
Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs
No Significant Event
Official Name : Janice Soreth, Associate Commissioner for Special Medical Programs
No Significant Event
Official Name : CAPT Denise Hinton, Acting Chief Scientist
No Significant Event
Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date : 06/26/2017 - 06/26/2017
Location : Washington, D.C.
Subject : Lupus Foundation of America: What Do You Believe are the Barriers to Lupus Research/Drug Development?
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date : 06/29/2017 - 06/29/2017
Location : Silver Spring, MD
Subject : Regulation of Hearing Aids
FDA Participant/Group : JONETTE FOY; VASANT DASIKA; IAN OSTERMILLER; SRINIVAS NANDKUMAR; SHU-CHEN PENG; ERIC MANN;
Non FDA Participant/Group : Marc Lundeberg, Tom Tedeschi, Heinz Ruch, Raimondo Fusco, Nate Brown (Amplifon Americas);
Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name : Steven Solomon, Director, Center for Veterinary Medicine
Event Date : 06/28/2017 - 06/28/2017
Location : Washington, D.C.
Subject : Pew Charitable Trusts Quarterly Meeting: Items of Mutual Interest
FDA Participant/Group : ERIK METTLER; STEVEN VAUGHN; LAURA BRADBARD; MICHAEL MURPHY; WILLIAM FLYNN; DANIEL MCCHESNEY; NADINE STEINBERG;
Non FDA Participant/Group : Karin Hoelzer, Kathy Talkington, Kyle Kinner, Nora Wong (Pew Charitable Trusts);
Event Date : 06/30/2017 - 06/30/2017
Location : Silver Spring, MD
Subject : Phibro Animal Health: Items of Mutual Interest
FDA Participant/Group : WILLIAM FLYNN;
Non FDA Participant/Group : Denise Esposito (Covington & Burling, LLP.); Judy Weinstein (Phibro Animal Health);
Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
Event Date : 06/25/2017 - 06/28/2017
Location : Denver, CO
Subject : Teratology Society Annual Meeting: Changes in Serum Lipid Profiles in Neonatal Monkeys Associated with Sevoflurane-Induced Neurotoxicity
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Elizabeth H. Dickinson, Esq., Chief Counsel
No Significant Event